Description / Scope​ of the Technical Need.

We are looking for easy to use, accessible, reliable & actionable diagnostic solutions that enhance early detection and condition awareness. Our focus is on delivering to our consumers user-friendly, reliable, easily accessible and actionable diagnostic solutions in the following areas:​
 

  • Liver health – supporting condition awareness for NAFLD/MAFLD​
  • Allergy – aiding in diagnosis, prevention, and treatment​
  • Gut health – including actionable microbiome analysis​


Our goal is to ensure that users can understand the why and how, feel motivated to take action, and clearly observe the impact of the actions taken.​

Background.

We believe healthtech can unlock the power of self-care by enabling condition awareness and informed decision-making. Our goal is to empower consumers with accurate, accessible, and actionable information—especially for silent diseases and complex conditions where symptoms are hard to trace back to their root causes.​
 

This approach supports:​
 

  • Prevention & Early Intervention – Giving consumers and healthcare providers the tools to reduce risks and manage conditions before they become severe.
  • Faster, More Effective and More Personalized Treatment – Delivering quicker, more effective, and tailored treatment options that improve outcomes.​
  • Proven Results – Offering solutions backed by real-world data and measurable impact.​

Key Success Criteria.

Must-have Requirements.

  • At-home and point-of-care diagnostics.​
  • Non-invasive tests or minimally invasive.​
  • Instant diagnostics with real-time results.​
  • High sensitivity to key biomarkers for accurate detection of health conditions and/or monitoring of progress and treatment response.​
  • Strong clinical and scientific evidence supporting the Diagnostic device.​
  • Compliance with medical device regulations and quality standards.​
  • Proprietary technology or intellectual property.​

 

Preferred Requirements. ​

  • At or near industrialization stage, with validated regulatory and quality compliance.​
  • Standalone diagnostic capability, providing comprehensive results that minimize the need for follow-up with a doctor.​
  • Validated product-market fit.​
  • Low cost for high accessibility, with a design optimized for low cost of goods (COGS) to ensure competitive pricing.​
  • Solutions integrated into existing consumer platforms or devices (e.g. smartphones, wearables) are preferred over standalone, single-purpose tools.​

 

Approaches​ not of interest.

  • Invasive tests.​
  • Standard Stool tests.​
  • Deferred analysis (at-home or point-of-care sampling with remote lab processing).​
  • Rx products.​

 

Target Group​.

These healthtech solutions can serve diverse audiences/users including:​

  • consumer-facing (children and adults), and​
  • HCP-facing

 

Geographies​.

Global

Submit solution.

Reach 
out.

Have a question or simply want to know more?

Drop us a line.

Any question or adverse reaction related to our products must be addressed via www.sanofi.com.